By Kate Madden Yee, AuntMinnie.com staff writer
November 17, 2010
Tuesday, November 30 | 11:50 a.m.-12:00 p.m. | SSG07-09 | Room S102DUsing gadolinium-based contrast agents with enhanced MRI studies is safe, according to researchers from Weill Cornell Medical College and Columbia University in New York City.
In this Tuesday session, Martin Prince, MD, PhD, and colleagues will present findings from a study they conducted to evaluate the incidence of immediate adverse events following the use of these contrast agents.
The study included voluntarily reported adverse events that occurred between January 2000 and December 2009. Prince's team calculated the rates of adverse events as the number of events divided by the number of doses for each gadolinium-based contrast agent -- data which the group obtained from hospital purchasing records and MRI log books for contrast-enhanced examinations.
Over the 10-year time frame, 157,497 gadolinium-based contrast agent injections were performed and 94 adverse events were reported. Of the adverse events, 74 were categorized as mild, 16 as moderate, and just four as severe, according to American College of Radiology criteria, the team found.